Popping heartburn pills doesn't up dementia risk

Exercise may sharpen the mind by repairing the brain's protective shield. Researchers found that physical activity prompts the liver to release an enzyme that removes a harmful protein, causing the blood-brain barrier to become leaky with age.

Alzheimer's has long been considered irreversible, but new research challenges that assumption. Scientists discovered that severe drops in the brain's energy supply help drive the disease, and restoring that balance can reverse damage, even in advanced cases.

A new study led by researchers at University College London (UCL) shows that chronic exposure to toxic air can significantly diminish the health benefits of regular physical activity.

Researchers discovered that raising the protein Sox9 can help the brain's astrocytes clear out toxic plaque buildup linked to Alzheimer's.

Hypertension may impair the brain far earlier than previously understood -- even before a measurable rise in blood pressure occurs -- according to a new preclinical study from Weill Cornell Medicine. The changes help explain why hypertension is a major risk factor for developing cognitive disorders, such as vascular cognitive impairment and Alzheimer's disease.

In a study published November 5 in Nature, the team found that microglia with lower levels of a transcription factor called PU.1 and higher expression of a receptor known as CD28 help reduce brain inflammation.

About 100,000 of the estimated million persons in the United States with multiple sclerosis (MS) have a progressive form of the disease, with symptoms worsening over time or following periods of remission.

Scientists discovered that tiny messengers released by fat tissue, called extracellular vesicles, can carry harmful signals that accelerate the buildup of amyloid-b plaques in the brain.

Dr Dangs Lab has unveiled Dendrite Dx, an integrated ecosystem for early, non-invasive Alzheimer's diagnosis on 'World Alzheimer's Day.'

The Researchers at the University of California San Diego School of Medicine have identified a new investigational drug that shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease linked to obesity and type 2 diabetes that can lead to cirrhosis, liver failure, and even liver cancer.